Logo

Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian

Author(s):
Seyed Moayed AlavianSeyed Moayed Alavian1,*, Behzad HajarizadehBehzad Hajarizadeh2, Bashir HajibeigiBashir Hajibeigi2, Taher DoroudiTaher Doroudi2, Amir Kambiz HamadanizadehAmir Kambiz Hamadanizadeh2, Koroush AbarKoroush Abar2
1Baqiyatallah University of Medical Sciences, Tehran Hepatitis Center, Study Group of Interferonin Iran, manager@iranhepgroup.info, Tehran, IR.Iran
2Baqiyatallah University of Medical Sciences, Tehran Hepatitis center, Tehran, IR.Iran


Hepatitis Monthly:Vol. 4, issue 7; 53-58
Article type:Research Article
How to Cite:Seyed Moayed AlavianBehzad HajarizadehBashir HajibeigiTaher DoroudiAmir Kambiz HamadanizadehKoroush Abaret al.Efficacy and Safety of Pegylated Interferon Alfa-2a plus Ribavirin for Treatment of Chronic Hepatitis C and Cirrhosis in Iranian.Hepat Mon.4(7):53-58.

Abstract

Full Text

Full text is available in PDF

comments

Leave a comment here

Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles